Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) Who Have Already Tried Treatments Taken by Mouth or by InjectionTerminated
NCT05732454Phase 2, Phase 3Updated May 8, 2025
Sponsor: Pfizer
Atopic Dermatitis · Atopic Dermatitis, Unspecified · Eczema · Eczema, Atopic
United States, Canada, Czechia, Poland
A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy ToddlersCompleted
NCT06116591Phase 2Updated May 8, 2025
Sponsor: Pfizer
Healthy Participants
Finland, Poland
Thailand ATTR-CM RegistryRecruiting
NCT06338696N/AUpdated May 8, 2025
Sponsor: Mahidol University
Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Thailand
A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants.Completed
NCT05994963Phase 1Updated May 6, 2025
Sponsor: Pfizer
Healthy
Belgium
A Study of PF-07260437 in Advanced or Metastatic Solid TumorsTerminated
NCT05067972Phase 1Updated May 6, 2025
Sponsor: Pfizer
Ovarian Neoplasms · Endometrial Neoplasms · Breast Neoplasms
United States, Puerto Rico
Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113Completed
NCT04070768Phase 1Updated May 4, 2025
Sponsor: John Quigley
Acute Myeloid Leukemia
United States
Combining Varenicline and Bupropion for Smoking CessationCompleted
NCT00943618Phase 3Updated May 4, 2025
Sponsor: M.D. Anderson Cancer Center
Smoking Cessation
United States
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer PatientsCompleted
NCT00437372Phase 1Updated May 2, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Cancer · Head and Neck Cancer · Pelvic Cancer · Nervous System Neoplasms
United States
COVID-19 VaccinE Response in Rheumatology PatientsCompleted
NCT05080218Phase 4Updated May 2, 2025
Sponsor: Jeffrey Curtis
Rheumatoid Arthritis · Psoriatic Arthritis · Spondylarthritis
United States
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast CancerCompleted
NCT02040857Phase 2Updated Apr 29, 2025
Sponsor: Dana-Farber Cancer Institute
Breast Cancer
United States
A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Healthy AdultsWithdrawn
NCT06661694Phase 1Updated Apr 24, 2025
Sponsor: Pfizer
Healthy
Belgium
A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Healthy Adults.Completed
NCT06105983Phase 1Updated Apr 24, 2025
Sponsor: Pfizer
Healthy
Belgium
A Study to Learn More About the Menopausal Hormone Therapies in KoreaCompleted
NCT06033521N/AUpdated Apr 18, 2025
Sponsor: Pfizer
Menopause · Bone Demineralization
South Korea
A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.Completed
NCT05873751N/AUpdated Apr 17, 2025
Sponsor: Pfizer
Gonorrhea · Chlamydia · Meningococcal Vaccines
United States
LITMUS Imaging StudyActive Not Recruiting
NCT05479721N/AUpdated Apr 16, 2025
Sponsor: University of Oxford
NAFLD · NASH · NASH - Nonalcoholic Steatohepatitis · Fibrosis, Liver
United States, Finland, France, Germany, Greece +5 more
Metastatic Breast Cancer in AustriaRecruiting
NCT03870620N/AUpdated Apr 10, 2025
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Breast Cancer · Breast Carcinoma · Breast Tumor
Austria
A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy AdultsCompleted
NCT06172348Phase 1Updated Apr 10, 2025
Sponsor: Pfizer
Healthy Volunteers
Belgium
A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy AdultsCompleted
NCT05907395Phase 1Updated Apr 10, 2025
Sponsor: Pfizer
Healthy Participants
Belgium
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic StrokeTerminated
NCT03192215Phase 3Updated Apr 9, 2025
Sponsor: Columbia University
Stroke
United States, Canada
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)Completed
NCT01172652Phase 4Updated Apr 8, 2025
Sponsor: VA Palo Alto Health Care System
Bipolar Disorder · Panic Disorder · Generalized Anxiety Disorder
United States
A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide AloneCompleted
NCT02288247Phase 3Updated Apr 8, 2025
Sponsor: Astellas Pharma Europe Ltd.
Metastatic Castration Resistant Prostate Cancer
Austria, Belgium, Czechia, France, Germany +11 more
Study of Axitinib for Downstaging Large Renal Tumors Not Primarily Suitable for Partial Nephrectomy (AXIPAN)Completed
NCT02597322Phase 2Updated Apr 6, 2025
Sponsor: Assistance Publique - Hôpitaux de Paris
cT2a N0NxM0 Renal Tumor
France
Changes of Depression After First-year of Tofacitinib in RA PatientsCompleted
NCT03992781N/AUpdated Apr 6, 2025
Sponsor: Pfizer
Rheumatoid Arthritis
Czechia
A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast CancerCompleted
NCT02091960Phase 2Updated Apr 4, 2025
Sponsor: Astellas Pharma Global Development, Inc.
HER2 Amplified · Advanced Breast Cancer · Human Epidermal Growth Factor Receptor 2 (HER2)
United States, Belgium, Canada, Italy, Spain +1 more
Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaActive Not Recruiting
NCT03498378Phase 1Updated Apr 3, 2025
Sponsor: Kathryn Gold
Head and Neck Squamous Cell Carcinoma
United States

Previous page Next page